MannKind Corp
MNKD
#5891
Rank
A$1.79 B
Marketcap
A$5.57
Share price
-0.75%
Change (1 day)
-36.77%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): A-$0.10

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is A-$0.09792. In 2025 the company made an earnings per share (EPS) of A$0.02798 a decrease over its 2024 EPS that were of A$0.14.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.10-462.85%
2025A$0.02798-80%
2024A$0.14
2022A-$0.486.25%
2021A-$0.4528%
2020A-$0.35-7.41%
2019A-$0.38
2017A-$1.55-188.1%
2016A$1.76-128.31%
2015A-$6.2374.51%
2014A-$3.57-20.31%
2013A-$4.48-32.63%
2012A-$6.64-28.03%
2011A-$9.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$6.01-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$39.48-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.00-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$4.08-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.78 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA